In utero exposure to selective serotonin reuptake inhibitors and risk for autism spectrum disorder

Nicole B. Gidaya, Brian K. Lee, Igor Burstyn, Michael Yudell, Erik L. Mortensen, Craig J. Newschaffer

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

We investigated whether there is an association between increased risk for autism spectrum disorders (ASD) and selective serotonin reuptake inhibitors (SSRIs) used during pregnancy. This study used Denmark’s health and population registers to obtain information regarding prescription drugs, ASD diagnosis, and health and socioeconomic status. There were 1.5 % of cases and 0.7 % of controls exposed to SSRIs during the pregnancy period, and higher effect estimates observed with longer use. We found evidence that in utero exposure to SSRIs increases a child’s risk associated with ASD. These results, while adding to the limited knowledge on prenatal pharmacological exposures as potential ASD risk factors, need to be balanced against the benefits of indicated medication use by pregnant mothers.

Original languageEnglish (US)
Pages (from-to)2558-2567
Number of pages10
JournalJournal of Autism and Developmental Disorders
Volume44
Issue number10
DOIs
StatePublished - Jan 1 2014

Fingerprint

Serotonin Uptake Inhibitors
Pregnancy
Prescription Drugs
Denmark
Social Class
Health Status
Registries
Mothers
Pharmacology
Autism Spectrum Disorder
Health

All Science Journal Classification (ASJC) codes

  • Developmental and Educational Psychology

Cite this

Gidaya, Nicole B. ; Lee, Brian K. ; Burstyn, Igor ; Yudell, Michael ; Mortensen, Erik L. ; Newschaffer, Craig J. / In utero exposure to selective serotonin reuptake inhibitors and risk for autism spectrum disorder. In: Journal of Autism and Developmental Disorders. 2014 ; Vol. 44, No. 10. pp. 2558-2567.
@article{01053e0a3f7844ff92c93fcad5cb1080,
title = "In utero exposure to selective serotonin reuptake inhibitors and risk for autism spectrum disorder",
abstract = "We investigated whether there is an association between increased risk for autism spectrum disorders (ASD) and selective serotonin reuptake inhibitors (SSRIs) used during pregnancy. This study used Denmark’s health and population registers to obtain information regarding prescription drugs, ASD diagnosis, and health and socioeconomic status. There were 1.5 {\%} of cases and 0.7 {\%} of controls exposed to SSRIs during the pregnancy period, and higher effect estimates observed with longer use. We found evidence that in utero exposure to SSRIs increases a child’s risk associated with ASD. These results, while adding to the limited knowledge on prenatal pharmacological exposures as potential ASD risk factors, need to be balanced against the benefits of indicated medication use by pregnant mothers.",
author = "Gidaya, {Nicole B.} and Lee, {Brian K.} and Igor Burstyn and Michael Yudell and Mortensen, {Erik L.} and Newschaffer, {Craig J.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/s10803-014-2128-4",
language = "English (US)",
volume = "44",
pages = "2558--2567",
journal = "Journal of Autism and Developmental Disorders",
issn = "0162-3257",
publisher = "Springer New York",
number = "10",

}

In utero exposure to selective serotonin reuptake inhibitors and risk for autism spectrum disorder. / Gidaya, Nicole B.; Lee, Brian K.; Burstyn, Igor; Yudell, Michael; Mortensen, Erik L.; Newschaffer, Craig J.

In: Journal of Autism and Developmental Disorders, Vol. 44, No. 10, 01.01.2014, p. 2558-2567.

Research output: Contribution to journalArticle

TY - JOUR

T1 - In utero exposure to selective serotonin reuptake inhibitors and risk for autism spectrum disorder

AU - Gidaya, Nicole B.

AU - Lee, Brian K.

AU - Burstyn, Igor

AU - Yudell, Michael

AU - Mortensen, Erik L.

AU - Newschaffer, Craig J.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - We investigated whether there is an association between increased risk for autism spectrum disorders (ASD) and selective serotonin reuptake inhibitors (SSRIs) used during pregnancy. This study used Denmark’s health and population registers to obtain information regarding prescription drugs, ASD diagnosis, and health and socioeconomic status. There were 1.5 % of cases and 0.7 % of controls exposed to SSRIs during the pregnancy period, and higher effect estimates observed with longer use. We found evidence that in utero exposure to SSRIs increases a child’s risk associated with ASD. These results, while adding to the limited knowledge on prenatal pharmacological exposures as potential ASD risk factors, need to be balanced against the benefits of indicated medication use by pregnant mothers.

AB - We investigated whether there is an association between increased risk for autism spectrum disorders (ASD) and selective serotonin reuptake inhibitors (SSRIs) used during pregnancy. This study used Denmark’s health and population registers to obtain information regarding prescription drugs, ASD diagnosis, and health and socioeconomic status. There were 1.5 % of cases and 0.7 % of controls exposed to SSRIs during the pregnancy period, and higher effect estimates observed with longer use. We found evidence that in utero exposure to SSRIs increases a child’s risk associated with ASD. These results, while adding to the limited knowledge on prenatal pharmacological exposures as potential ASD risk factors, need to be balanced against the benefits of indicated medication use by pregnant mothers.

UR - http://www.scopus.com/inward/record.url?scp=84912027605&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84912027605&partnerID=8YFLogxK

U2 - 10.1007/s10803-014-2128-4

DO - 10.1007/s10803-014-2128-4

M3 - Article

C2 - 24803368

AN - SCOPUS:84912027605

VL - 44

SP - 2558

EP - 2567

JO - Journal of Autism and Developmental Disorders

JF - Journal of Autism and Developmental Disorders

SN - 0162-3257

IS - 10

ER -